Adrian F. Hernandez

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Brian Claggett et al. · New England Journal of Medicine · 2022 · 2.7K citations · Full text

Medicine, Cardiology, Pharmacology +17

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

Paul A. Heidenreich, Biykem Bozkurt, David Aguilar et al. · Journal of the American College of Cardiology · 2022 · 2.6K citations

Medicine, Cardiology, Clinical Cardiology +13

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

Rury R. Holman, M. Angelyn Bethel, Robert J. Mentz et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Diuretic Strategies in Patients with Acute Decompensated Heart Failure

G. Michael Felker, Kerry L. Lee, David A. Bull et al. · New England Journal of Medicine · 2011 · 1.7K citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +12